LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.92 | 84.90 | 2247 | 2237 | 1.0041 | 1.0018 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.92 | 84.90 | 2344 | 2237 | 1.0475 | 1.0198 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.92 | 84.90 | 52 | 2237 | 0.0232 | -0.0986 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.92 | 84.90 | 1977 | 2237 | 0.8835 | 0.9482 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.92 | 84.90 | 42 | 2237 | 0.0188 | -0.1385 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.92 | 84.90 | 2142 | 2237 | 0.9572 | 0.9816 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 31.62 | 84.90 | 2349 | 2449 | 0.9589 | 0.9828 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 31.62 | 84.90 | 2382 | 2449 | 0.9724 | 0.9885 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 31.62 | 84.90 | 2477 | 2449 | 1.0111 | 1.0046 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 31.62 | 84.90 | 2530 | 2449 | 1.0328 | 1.0133 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 31.62 | 84.90 | 72 | 2449 | 0.0294 | -0.0334 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 31.62 | 84.90 | 2153 | 2449 | 0.8789 | 0.9475 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 31.62 | 84.90 | 63 | 2449 | 0.0257 | -0.0596 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 31.62 | 84.90 | 2369 | 2449 | 0.9671 | 0.9862 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 33.32 | 84.90 | 2578 | 2722 | 0.9470 | 0.9783 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 33.32 | 84.90 | 2603 | 2722 | 0.9561 | 0.9822 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 33.32 | 84.90 | 2733 | 2722 | 1.0039 | 1.0016 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 33.32 | 84.90 | 2784 | 2722 | 1.0226 | 1.0090 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 33.32 | 84.90 | 86 | 2722 | 0.0316 | 0.0026 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 33.32 | 84.90 | 2380 | 2722 | 0.8742 | 0.9470 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 33.32 | 84.90 | 85 | 2722 | 0.0312 | 0.0002 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 33.32 | 84.90 | 2612 | 2722 | 0.9595 | 0.9835 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 35.03 | 84.90 | 2802 | 2991 | 0.9367 | 0.9747 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 35.03 | 84.90 | 2829 | 2991 | 0.9457 | 0.9784 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 35.03 | 84.90 | 2958 | 2991 | 0.9889 | 0.9957 | MN20160318_Q02 | D05 |